Zhou Y - Search Results

1

Establishment of a novel human induced pluripotent stem cell line (SIPDi001-A) with compound heterozygous mutations in the UBR7 gene from a Li-Campeau syndrome patient.

Li B, Zhou Y, Che F, Zhou R, Mo L, Zhang L, Wang G, Yang Y. Li B, et al. Among authors: zhou y, zhou r. Stem Cell Res. 2023 Sep;71:103165. doi: 10.1016/j.scr.2023.103165. Epub 2023 Jul 9. Stem Cell Res. 2023. PMID: 37478672 Free article.

2

Generation of two induced pluripotent stem cell lines (XACHi0010-A, XACHi0011-A) from a Chinese family with combined oxidative phosphorylation deficiency carrying homozygous and heterozygous C1QBP-L275F mutation.

Zhang Y, Wang J, Zhou Y, Li H, Li A, Tan X, Wang G, Lei M. Zhang Y, et al. Among authors: zhou y. Stem Cell Res. 2020 Jul 15;47:101912. doi: 10.1016/j.scr.2020.101912. Online ahead of print. Stem Cell Res. 2020. PMID: 32707487 Free article.

3

Establishment of iPSC line from a Chinese infant (XACHi012-A) with Jervell and Lange-Nielsen syndrome carrying combined KCNQ1 frameshift c.431delC(p.I145Sfs*92) and nonsense c.1175G > A (p.W392X) variants and two iPSC lines from the parents (XACHi013-A, XACHi014-A).

Zhou Y, Wang J, Li H, Li A, Wang G, Tan X, Lei M, Zhang Y. Zhou Y, et al. Stem Cell Res. 2021 May;53:102391. doi: 10.1016/j.scr.2021.102391. Epub 2021 May 11. Stem Cell Res. 2021. PMID: 34088017 Free article.

4

Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.

Wang T, Zhou Y, Zhou R, Huang W, Wang J, Li H, Lei M, Tan X, Zhang Y. Wang T, et al. Among authors: zhou y, zhou r. Stem Cell Res. 2021 Oct;56:102509. doi: 10.1016/j.scr.2021.102509. Epub 2021 Aug 19. Stem Cell Res. 2021. PMID: 34438161 Free article.

5

The Biphasic Effect of Retinoic Acid Signaling Pathway on the Biased Differentiation of Atrial-like and Sinoatrial Node-like Cells from hiPSC.

Liu F, Long D, Huang W, Peng W, Lan H, Zhou Y, Dang X, Zhou R. Liu F, et al. Among authors: zhou y, zhou r. Int J Stem Cells. 2022 Aug 30;15(3):247-257. doi: 10.15283/ijsc21148. Epub 2022 Feb 28. Int J Stem Cells. 2022. PMID: 35220280 Free PMC article.

6

Generation of two heterozygous GAA mutation-carrying human induced pluripotent stem cell lines (XACHi005-A, XACHi006-A) from parents of an infant with Pompe disease.

Huang W, Zhou Y, Wang J, Jiang C, Zhang Y, Zhou R. Huang W, et al. Among authors: zhou y, zhou r. Stem Cell Res. 2022 Oct;64:102934. doi: 10.1016/j.scr.2022.102934. Epub 2022 Oct 3. Stem Cell Res. 2022. PMID: 36240644 Free article.

7

Generation of one human induced pluripotent stem cell line (XACHi004-A) with heterozygous mutation of RYR2 gene from an atrial fibrillation patient.

Zhou Y, Jiang C, Wang J, Huang W, Zhang Y, Zhou R. Zhou Y, et al. Among authors: zhou r. Stem Cell Res. 2022 Dec;65:102955. doi: 10.1016/j.scr.2022.102955. Epub 2022 Oct 31. Stem Cell Res. 2022. PMID: 36335801 Free article.

8

Patient-specific induced pluripotent stem cell properties implicate Ca²⁺-homeostasis in clinical arrhythmia associated with combined heterozygous RYR2 and SCN10A variants.

Zhou Y, Huang W, Liu L, Li A, Jiang C, Zhou R, Wang J, Tan X, Huang CL, Zhang Y. Zhou Y, et al. Among authors: zhou r. Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220175. doi: 10.1098/rstb.2022.0175. Epub 2023 May 1. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37122207 Free PMC article.

9

Generation of cardiomyocytes from human-induced pluripotent stem cells resembling atrial cells with ability to respond to adrenoceptor agonists.

Ahmad FS, Jin Y, Grassam-Rowe A, Zhou Y, Yuan M, Fan X, Zhou R, Mu-U-Min R, O'Shea C, Ibrahim AM, Hyder W, Aguib Y, Yacoub M, Pavlovic D, Zhang Y, Tan X, Lei M, Terrar DA. Ahmad FS, et al. Among authors: zhou y, zhou r. Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220312. doi: 10.1098/rstb.2022.0312. Epub 2023 May 1. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37122218 Free PMC article.

10

Mitochondrial dysfunction is associated with hypertrophic cardiomyopathy in Pompe disease-specific induced pluripotent stem cell-derived cardiomyocytes.

Huang W, Zhou R, Jiang C, Wang J, Zhou Y, Xu X, Wang T, Li A, Zhang Y. Huang W, et al. Among authors: zhou y, zhou r. Cell Prolif. 2024 Apr;57(4):e13573. doi: 10.1111/cpr.13573. Epub 2023 Nov 2. Cell Prolif. 2024. PMID: 37916452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,752 results

Search Page

Filters